HESTER BIOSCIENCES LIMITED |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 1,661 INR | -1.19% |
|
+2.23% | +13.82% |
| Feb. 29 | Hester Biosciences Names COO | MT |
| Feb. 29 | Hester Biosciences Limited Announces Executive Changes | CI |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registration
Hester Biosciences Limited is an India-based animal healthcare company. The Company is engaged in providing vaccines, health products and diagnostic laboratory services. The Company operates through four segments: Poultry Healthcare, Animal Healthcare, Petcare, and Others. The Animal Healthcare vaccines include Goat Pox Vaccine, Live Brucella, PPR Vaccine - Nigerian 75/1, and PPR Vaccine - Sungri/96. Its Poultry Healthcare products include Gumboro I, Gumboro I +, Inactivated Chick ND, Inactivated Coryza, Inactivated Coryza+, Inactivated EDS, Inactivated FC3, Inactivated FC4, Inactivated IB, Inactivated IB+, Inactivated IB-H52, Inactivated IBD, Inactivated IBD ND, Inactivated IBD ND EDS, Inactivated ND IB, Inactivated Pullet ND, Live B1, Live B1 M48, Live FP, Live H120, Live Las, Live Las Mas, Live M48, Live R2B, Live S-One, MD-Bivalent HVT+SB1, MD-HVT (FD), and Thermostable ND. Its Petcare products include Cefshot Tazo Injection, Hestacef CV, Hestacef DS, Hestaflam Tablet and Hestaliv.
Sector
Pharmaceuticals
Calendar
2024-05-14
- Q4 2024 Earnings Release (Projected)
Annual profits - Rate of surprise
| 1st Jan change | Capi. | |
|---|---|---|
| +13.82% | 172M | |
| -22.30% | 68.94B | |
| +18.88% | 3.43B | |
| -3.62% | 3.22B | |
| -2.87% | 1.46B | |
| -15.41% | 1.38B | |
| -4.30% | 1.26B | |
| -27.74% | 1.21B | |
| -13.54% | 1.14B | |
| -2.99% | 1.02B |
- Stock Market
- Equities
- 524669 Stock
- News Hester Biosciences Limited
- CARE Maintains A- Rating on Hester Biosciences' Long-Term Bank Financing; Outlook Stable
